Holdings
iShares Genomics Immunology and Healthcare ETF
As of Jul 31, 2026, iShares Genomics Immunology and Healthcare ETF reported 46 positions worth US$183M. Largest: Bayer Ag, Twist Bioscience Corporation and Revolution Medicines, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Bayer Ag | 166K | US$9.18M | +8,819 | Jul 31, 2026 |
| Twist Bioscience Corporation | 99,937 | US$9.15M | −3,999 | Jul 31, 2026 |
| Revolution Medicines, Inc. | 46,352 | US$8.69M | −29,973 | Jul 31, 2026 |
| Regeneron Pharmaceuticals, Inc. | 10,887 | US$8.3M | +2,425 | Jul 31, 2026 |
| Genmab A/s | 28,069 | US$8.08M | +8,887 | Jul 31, 2026 |
| Incyte Corporation | 67,570 | US$8.08M | +8,279 | Jul 31, 2026 |
| Moderna, Inc. | 146K | US$7.99M | −73,622 | Jul 31, 2026 |
| Takeda Pharmaceutical Co. Ltd. | 225K | US$7.73M | +22,600 | Jul 31, 2026 |
| Merck & Company, Inc. | 57,270 | US$7.46M | −3,686 | Jul 31, 2026 |
| Vertex Pharmaceuticals Incorporated | 15,481 | US$7.39M | +2,136 | Jul 31, 2026 |